首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1021篇
  免费   42篇
  国内免费   8篇
耳鼻咽喉   3篇
儿科学   4篇
妇产科学   9篇
基础医学   64篇
口腔科学   24篇
临床医学   79篇
内科学   170篇
皮肤病学   6篇
神经病学   44篇
特种医学   66篇
外科学   92篇
综合类   14篇
预防医学   51篇
眼科学   3篇
药学   46篇
中国医学   2篇
肿瘤学   394篇
  2023年   120篇
  2022年   188篇
  2021年   102篇
  2020年   154篇
  2019年   57篇
  2018年   21篇
  2017年   36篇
  2016年   49篇
  2015年   31篇
  2014年   43篇
  2013年   42篇
  2012年   30篇
  2011年   17篇
  2010年   31篇
  2009年   25篇
  2008年   5篇
  2007年   29篇
  2006年   10篇
  2005年   10篇
  2004年   1篇
  2003年   5篇
  2002年   6篇
  2001年   5篇
  2000年   6篇
  1999年   5篇
  1998年   7篇
  1997年   5篇
  1996年   6篇
  1995年   6篇
  1994年   3篇
  1993年   4篇
  1992年   1篇
  1991年   2篇
  1990年   4篇
  1989年   4篇
  1988年   1篇
排序方式: 共有1071条查询结果,搜索用时 328 毫秒
1.
2.
BackgroundIsolated local recurrent or persistent esophageal cancer (EC) after curative intended definitive (dCRT) or neoadjuvant chemoradiotherapy (nCRT) with initially omitted surgery, is a potential indication for salvage surgery. We aimed to evaluate safety and efficacy of salvage surgery in these patients.Material and methodsA systematic literature search following PRISMA guidelines was performed using databases of PubMed/Medline. All included studies were performed in patients with persistent or recurrent EC after initial treatment with dCRT or nCRT, between 2007 and 2017. Survival analysis was performed with an inverse-variance weighting method.ResultsOf the 278 identified studies, 28 were eligible, including a total of 1076 patients. Postoperative complications after salvage esophagectomy were significantly more common among patients with isolated persistent than in those with locoregional recurrent EC, including respiratory (36.6% versus 22.7%; difference in proportion 10.9 with 95% confidence interval (CI) [3.1; 18.7]) and cardiovascular complications (10.4% versus 4.5%; difference in proportion 5.9 with 95% CI [1.5; 10.2]). The pooled estimated 30- and 90-day mortality was 2.6% [1.6; 3.6] and 8.0% [6.3; 9.8], respectively. The pooled estimated 3-year and 5-year overall survival (OS) were 39.0% (95% CI: [35.8; 42.2]) and 19.4% [95% CI:16.5; 22.4], respectively. Patients with isolated persistent or recurrent EC after initial CRT had similar 5-year OS (14.0% versus 19.7%, difference in proportion −5.7, 95% CI [-13.7; 2.3]).ConclusionsSalvage surgery is a potentially curative procedure in patients with locally recurrent or persistent esophageal cancer and can be performed safely after definitive or neoadjuvant chemoradiotherapy when surgery was initially omitted.  相似文献   
3.
目的 探讨单孔加一孔腹腔镜手术联合 ERAS 治疗高位直肠及乙状结肠癌的近期疗效。方法 回顾性分析 2017 年 11 月至2018 年 10 月在福建省肿瘤医院胃肠肿瘤外科进行加速康复外科干预的 92 例高位直肠及乙状结肠癌患者资料,根 据手术方式的不同,分为单孔加一孔手术联合快速康复外科组39 例及常规腹腔镜手术联合ERAS 组 53 例,对比两组围术 期情况。结果 两组患者基线资料无明显统计学差异(P > 0.05),且在手术时间、出血量、上下切缘、清扫淋巴结数量及 并发症方面无明显统计学差异(P > 0.05)。但单孔加一孔手术联合ERAS 组较常规手术联合ERAS 组,总切口长度更短 [(6.7±1.1)cm 比(8.5±1.3)cm,P=0.000],术后首次下床时间更早 [(22.2±5.2)h 比(27.1±7.9)h,P=0.001],首次排便 时间更早[(70.2±19.8)h比(83.1±20.4)h,P=0.005],术后第一天C反应蛋白值更低[(43.5±28.6)mg/L比(57.2±33.2) mg/L,P=0.038],术后住院时间更短 [(7.0±1.7)d 比(8.1±2.1)d,P=0.010],且术后 2~4 天疼痛评分更低(P < 0.05)。 结论 经验丰富的腔镜医师采用单孔加一孔手术治疗高位直肠及乙状结肠癌并联合 ERAS 干预是安全可行的,且单孔加一孔 手术可减低操作难度,具有疼痛轻、术后恢复快等优势,值得临床推广。  相似文献   
4.
生物信息学是一门交叉科学,通过综合运用数学、计算机科学和生物学的各种工具,来阐明和理解大量生物数据所包含的生物学意义。随着基因组学测序技术的不断发展,产生大量的生物学数据资源,从大数据中挖掘所蕴藏的生物学意义,已成为了当前亟待解决的主要任务之一。本文主要归纳总结基于特征基因的肝癌风险预测模型,为肝癌的早期检测、预后和治疗方案的优化提供新观点。  相似文献   
5.
6.
7.
BackgroundDetails of perioperative outcomes and survival after gastric cancer surgery in prior transplant recipients have received minimal research attention.MethodsWe performed an observational cohort study using the database of 20,147 gastric cancer patients who underwent gastrectomy at a single gastric cancer center in Korea. Forty-one solid organ recipients [kidney (n = 35), liver (n = 5), or heart (n = 1)] were matched with 205 controls using propensity score matching.ResultsOperation time, blood loss, and postoperative pain were similar between groups. Short-term complication rates were similar between transplantation and control groups (22.0% vs. 20.1%, P = 0.777). Transplantation group patients with stage 1 gastric cancer experienced no recurrence, while those with stage 2/3 cancer had significantly higher recurrence risk compared to the controls (P = 0.049). For patients with stage 1 cancer, the transplantation group had a significantly higher rate of non-gastric cancer-related deaths compared to the controls (19.2% vs. 1.4%, P = 0.001). For those with stage 2/3 cancer, significantly lower proportion of the transplantation group received adjuvant chemotherapy compared to the control group (26.7% vs. 80.3%, P < 0.001). The transplantation group had a higher (albeit not statistically significant) rate of gastric cancer-related deaths compared to the controls (40.0% vs. 18.0%, P = 0.087).ConclusionTransplant recipients and non-transplant recipients exhibited similar perioperative and short-term outcomes after gastric cancer surgery. From long-term outcome analyses, we suggest active surveillance for non-gastric cancer-related deaths in patients with early gastric cancer, as well as strict oncologic care in patients with advanced cancer, as effective strategies for transplant recipients.  相似文献   
8.
9.
10.
目的:探讨结直肠平滑肉瘤的临床特点,诊断方法、手术治疗要点以及 局部复发的因素。方法:对我院1976年1月-2002年1月间收治的9例结直肠平滑肌肉瘤患者的临床资料进行回顾性分析。结果:结肠平滑肌肉瘤2例,直肠平滑肌肉瘤7例,根治性切除7例,姑息性切除1例,局部切除1例,再次手术4例,三次手术2例。3年生成率55.6%,5年生存率22.2%,结论:提高疗效的关键取决于首次手术的正确性和彻底性,力争早期诊断较小的复发灶是提高5年生存率的重要因素,局部复发与术式选择密切相关,介入治疗及放疗对控制复发疗效不肯定。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号